← Open Payments lookup

STEFANIA FYNN-AIKINS: Open Payments

NPI 1508955402 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,429 in 38 payments from 12 companies in 2025. Trend: 2023 $1,104 · 2024 $1,935 · 2025 $1,429

Food & beverage: $1,429
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$246
Neurocrine BioSciences, Inc.5$208
Vanda Pharmaceuticals Inc.5$191
ABBVIE INC.11$171
Alkermes, Inc.2$142
Janssen Scientific Affairs, LLC1$131
E.R. Squibb & Sons, L.L.C.1$125
Axsome Therapeutics, Inc.5$93
Otsuka America Pharmaceutical, Inc.3$53
Janssen Pharmaceuticals, Inc1$32

Products named: CAPLYTA, INGREZZA, FANAPT, VRAYLAR, INVEGA SUSTENNA, COBENFY, LYBALVI, Auvelity.

Industry payments across NY — which companies pay providers there.